1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2010

TitleJournalYearCitations
H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAMCancer Research2010274
Aptamer-based tumor-targeted drug delivery for photodynamic therapyACS Nano2010258
Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cellsBioconjugate Chemistry2010216
CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cellsOncogene2010132
Early alpha-fetoprotein response predicts treatment efficacy of antiangiogenic systemic therapy in patients with advanced hepatocellular carcinomaCancer2010129
Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinomaBritish Journal of Cancer2010110
Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinomaJournal of Hepatology2010107
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): a meta-regression approachJournal of Hepatology2010105
Epigenetic influences of low-dose bisphenol A in primary human breast epithelial cellsToxicology and Applied Pharmacology201095
Significance of Aurora B overexpression in hepatocellular carcinoma. Aurora B Overexpression in HCCBMC Cancer201083
Induction of DNA damage-inducible gene GADD45beta contributes to sorafenib-induced apoptosis in hepatocellular carcinoma cellsCancer Research201069
Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivationJournal of Hepatology201061
Development of pH sensitive 2-(diisopropylamino)ethyl methacrylate based nanoparticles for photodynamic therapyNanotechnology201053
Liver Cancer Working Group reportJapanese Journal of Clinical Oncology201051
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinomaMedical Oncology201049
E2A-positive gastric MALT lymphoma has weaker plasmacytoid infiltrates and stronger expression of the memory B-cell-associated miR-223: possible correlation with stage and treatment responseModern Pathology201043
Geographic difference in survival outcome for advanced hepatocellular carcinoma: implications on future clinical trial designContemporary Clinical Trials201041
Second-line treatments after first-line gefitinib therapy in advanced nonsmall cell lung cancerInternational Journal of Cancer201040
Unique features of breast cancer in Asian women--breast cancer in Taiwan as an exampleJournal of Steroid Biochemistry and Molecular Biology201037
Efficacy and safety of cisplatin/pemetrexed versus cisplatin/gemcitabine as first-line treatment in East Asian patients with advanced non-small cell lung cancer: results of an exploratory subgroup analysis of a phase III trialJournal of Thoracic Oncology201036
The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cellsMolecular Carcinogenesis201033
Bortezomib suppresses focal adhesion kinase expression via interrupting nuclear factor-kappa BLife Sciences201029
O(6)-Methylguanine-DNA methyltransferase expression and prognostic value in brain metastases of lung cancersLung Cancer201027
Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptorsJournal of Thoracic Oncology201026
Hepatic arterial infusion of chemotherapy for advanced hepatocellular carcinomaAsia-Pacific Journal of Clinical Oncology201023